What is Total Cholesterol / HDL Ratio?
The total/HDL ratio divides total cholesterol by HDL cholesterol to yield a dimensionless number that combines the absolute amount of circulating cholesterol and the protective fraction in a single figure. A higher ratio means proportionally less protective HDL per unit of total cholesterol — a pattern that tracks with higher cardiovascular risk at the population level. The ratio was historically widely used in Framingham-derived tools and remains a standard component of risk calculation in some international guidelines. In the Dutch and European context (SCORE2, NHG, ESC/EAS), the total/HDL ratio has largely been replaced by non-HDL cholesterol (total minus HDL) and ApoB as primary risk markers. The reason: non-HDL and ApoB count all atherogenic particles without dividing by the protective fraction, giving a cleaner picture of atherogenic burden. The total/HDL ratio remains widely reported on results forms, however, and is useful as a quick summary when tracking interventions. A ratio below 4.0 is generally considered favourable for most adults; values above 5.0 are borderline and above 6.0 indicate elevated risk. These are orientation points, not clinical diagnostic criteria. For precise risk estimation, LDL, non-HDL cholesterol, ApoB, and individual risk models are more informative.
Why is Total Cholesterol / HDL Ratio relevant?
The total/HDL ratio is useful as a quick summary measure for tracking lipid profile changes over time. When LDL falls and HDL rises — the desired effect of better lifestyle, statin use, or weight loss — the ratio improves twice as fast as the individual values alone would suggest, making trends more visible. That makes it attractive as a monitoring tool, even if it is less precise for risk estimation than non-HDL or ApoB. The clinical limitation is the same as for any ratio: the same value can be reached via very different routes. A ratio of 3.5 driven by a low total cholesterol on statins at moderate HDL is a different picture from the same ratio driven by a high HDL without treatment. Without knowing the absolute components — total, LDL, HDL, triglycerides — the context needed to determine whether the ratio reflects a genuinely favourable profile is missing. For preventive blood panels the ratio is a quickly readable orientation on the lipid profile, but it does not replace the individual values. Particularly for people with diabetes, a family history of early cardiovascular disease, or elevated Lp(a), ApoB and LDL are the primary targets — and the total/HDL ratio is supplementary.
Total Cholesterol / HDL Ratio high or low — what it means
With every total/HDL ratio, always check the absolute values of total cholesterol, LDL, HDL, and triglycerides — only then can you tell whether the ratio reflects a genuinely favourable profile or a misleading combination. A low ratio driven by an unexpectedly low HDL (from smoking, high triglycerides, or inactivity) is a warning sign, not reassurance. A high ratio driven by a high total that is dominated by high HDL (athletic profile, genetically high HDL) is friendlier than the number suggests. Non-HDL cholesterol (total minus HDL) and ApoB give a more accurate picture of atherogenic burden and are therefore better suited as treatment targets than the total/HDL ratio. The ratio works well for trending and communicating about changes, but when there is doubt about actual cardiovascular risk, the individual components — and especially ApoB — take precedence. Total cholesterol and HDL are both relatively stable and do not strictly require a fasting sample, though a fasting draw gives a cleaner picture of triglycerides (which influence the LDL calculation). For a fair trend, compare results under comparable conditions — consistent timing, consistently fasted or non-fasted — and do not over-read a single outlier in the context of an otherwise stable profile.
Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.
Read about our scientific approach →